Massimo Volpe

58.8k total citations · 1 hit paper
844 papers, 21.5k citations indexed

About

Massimo Volpe is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Massimo Volpe has authored 844 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 558 papers in Cardiology and Cardiovascular Medicine, 175 papers in Endocrinology, Diabetes and Metabolism and 120 papers in Surgery. Recurrent topics in Massimo Volpe's work include Blood Pressure and Hypertension Studies (265 papers), Hormonal Regulation and Hypertension (128 papers) and Heart Failure Treatment and Management (93 papers). Massimo Volpe is often cited by papers focused on Blood Pressure and Hypertension Studies (265 papers), Hormonal Regulation and Hypertension (128 papers) and Heart Failure Treatment and Management (93 papers). Massimo Volpe collaborates with scholars based in Italy, United States and Germany. Massimo Volpe's co-authors include Speranza Rubattu, Sebastiano Sciarretta, Giuliano Tocci, Francesco Cosentino, Bruno Trimarco, Junichi Sadoshima, Carmine Savoia, Speranza Rubattu, Thomas F. Lüscher and Francesco Paneni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Massimo Volpe

799 papers receiving 20.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications

2022 228 citations Giovanna Gallo, Massimo Volpe et al. profile →

Peers

Countries citing papers authored by Massimo Volpe

Since Specialization

Citations

This map shows the geographic impact of Massimo Volpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Volpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Volpe more than expected).

Fields of papers citing papers by Massimo Volpe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Volpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Volpe. The network helps show where Massimo Volpe may publish in the future.

Co-authorship network of co-authors of Massimo Volpe

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Volpe. A scholar is included among the top collaborators of Massimo Volpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Volpe. Massimo Volpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blood pressure management in secondary prevention after myocardial infarction 2025 ·Cardiovascular Research ·Massimo Volpe, Giovanna Gallo, Tomasz J Guzik, Bryan Williams, Franz H. Messerli	0
2	Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Giuliano Tocci, Giacomo Tini, Massimo Volpe, Emanuele Barbato, Allegra Battistoni	5
3	The potential effect of natural antioxidants on endothelial dysfunction associated with arterial hypertension 2024 ·Frontiers in Cardiovascular Medicine ·(unknown), Cristina Carresi, Rocco Mollace, Roberta Macrì, Federica Scarano, Francesca Oppedisano, Jessica Maiuolo, Maria Serra, Stefano Ruga, Saverio Nucera, Annamaria Tavernese, Micaela Gliozzi, Vincenzo Musolino, Ernesto Palma, Carolina Muscoli, Speranza Rubattu, Maurizio Volterrani, Massimo Federici, Massimo Volpe, Vincenzo Mollace	18
4	What if flu vaccination is the most responsible thing to do for cardiovascular health in the upcoming season? 2023 ·European Heart Journal Supplements ·Massimo Volpe, Allegra Battistoni	2
5	Otto motivi per i quali i cardiologi non dovrebbero trascurare il problema “obesità”. Expert opinion per la pratica clinica 2023 ·Giornale italiano di cardiologia ·Massimo Volpe, Claudio Borghi, Matteo Cameli, Domenico Cianflone, Antonio Cittadini, Aldo P. Maggioni, Pasquale Perrone Filardi, Giuseppe Rosano, Michele Senni, Gianfranco Sinagra	2
6	Beneficial Effects of Citrus Bergamia Polyphenolic Fraction on Saline Load-Induced Injury in Primary Cerebral Endothelial Cells from the Stroke-Prone Spontaneously Hypertensive Rat Model 2023 ·Nutrients ·Rosita Stanzione, Maurizio Forte, Maria Cotugno, Francesca Oppedisano, Cristina Carresi, Simona Marchitti, Vincenzo Mollace, Massimo Volpe, Speranza Rubattu	3
7	Cardiovascular risk and the COVID-19 pandemic: A retrospective observational study in a population of healthcare professionals 2023 ·Nutrition Metabolism and Cardiovascular Diseases ·(unknown), (unknown), (unknown), (unknown), Giovanna Gallo, Giuliano Tocci, (unknown), (unknown), Emanuele Barbato, Massimo Volpe, (unknown)	2
8	Prevalence and clinical characteristics of isolated systolic hypertension in young: analysis of 24 h ambulatory blood pressure monitoring database 2021 ·Journal of Human Hypertension ·(unknown), (unknown), Vivianne Presta, (unknown), (unknown), Franca Bianchi, Andrea Ferrucci, Massimo Volpe, Giuliano Tocci	6
9	Un singolare caso di sindrome takotsubo secondaria 2018 ·Giornale italiano di cardiologia ·Luca Arcari, Luca Rosario Limite, Camillo Autore, Massimo Volpe, Beatrice Musumeci	1
10	Long-Term Sympathoinhibitory Effects of Surgically Induced Weight Loss in Severe Obese Patients 2014 ·Hypertension ·Gino Seravalle, M. Colombo, (unknown), (unknown), Massimo Volpe, Raffaella Dell’Oro, Giuseppe Mancia, Guıdo Grassı	61
11	Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan 2012 ·Expert Review of Cardiovascular Therapy ·Massimo Volpe	8
12	La politerapia in prevenzione cardiovascolare: problemi aperti 2012 ·Giornale italiano di cardiologia ·Massimo Volpe, (unknown), Francesco Paneni	4
13	Strategie per migliorare il controllo della pressione arteriosa in Italia: dalla stratificazione del rischio cardiovascolare globale alla terapia di combinazione. Documento di Indirizzo 2012 della Società Italiana dell’Ipertensione Arteriosa (SIIA) 2012 ·Giornale italiano di cardiologia ·Massimo Volpe, Ettore Ambrosioni, Claudio Borghi, Santina Cottone, Cesare Cuspidi, Nicola De Luca, Francesco Fallo, Claudio Ferri, Alberto Morganti, María Lorenza Muiesan, Riccardo Sarzani, Leonardo A. Sechi, Agostino Virdis, Giuliano Tocci, Enrico Agabiti‐Rosei, Bruno Trimarco, Alessandro Filippi, Giuseppe Mancia	3
14	Denervazione delle arterie renali nel trattamento dell’ipertensione arteriosa resistente: definizione della patologia, selezione dei pazienti e descrizione della procedura. Documento di Indirizzo 2012 della Società Italiana dell’Ipertensione Arteriosa (SIIA) 2012 ·Giornale italiano di cardiologia ·Massimo Volpe, Enrico Agabiti‐Rosei, Ettore Ambrosioni, Santina Cottone, Cesare Cuspidi, Claudio Borghi, Nicola De Luca, Francesco Fallo, Claudio Ferri, Giuseppe Mancia, Alberto Morganti, María Lorenza Muiesan, Riccardo Sarzani, Leonardo A. Sechi, Giuliano Tocci, Agostino Virdis	1
15	ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY 2012 ·SHILAP Revista de lepidopterología ·Ettore Malacco, Stefano Omboni, Massimo Volpe, A. Auteri, Alberto Zanchetti	13
16	Early Sympathetic Activation in the Initial Clinical Stages of Chronic Renal Failure 2011 ·Hypertension ·Guıdo Grassı, Fosca Quarti‐Trevano, Gino Seravalle, Francesca Arenare, Massimo Volpe, Silvia Furiani, Raffaella Dell’Oro, Giuseppe Mancia	243
17	Attuali concetti sullo sviluppo dell’insufficienza cardiaca nell’ipertensione 2011 ·Recenti Progressi in Medicina ·Francesca Palano, Francesco Paneni, Sebastiano Sciarretta, Giuliano Tocci, Massimo Volpe	11
18	Therapeutic implications of recent megatrials in hypertension: in favor of new drugs 2007 ·Journal of Nephrology ·Massimo Volpe, Giuliano Tocci	6
19	Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive Patients 2006 ·Hypertension ·Carmine Savoia, Rhian M. Touyz, Massimo Volpe, Ernesto L. Schiffrin	103
20	Long-term persistence with anti hypertensive drugs in new patients 2002 ·UCL Discovery (University College London) ·(unknown), A Sturani, Mirko Di Martino, (unknown), (unknown), Gianluca Baio, Stefano Buda, Massimo Volpe	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact